Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Severe Hemorrhagic Fever With Renal Syndrome
NCT06009042Phase 4Unknown
- Sponsor
- Tongji Hospital
- Start
- Jul 2022
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of intravenous immunoglobulin G in hemorrhagic fever with renal syndrome (HFRS), sponsored by Tongji Hospital. Status: unknown.
02
Drugs
intravenous immunoglobulin G
03
Conditions
hemorrhagic fever with renal syndrome (HFRS)
Beyond the preview
Go deeper on NCT06009042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06009042.